Seres Therapeutics Inc (MCRB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -73,003 | -40,133 | -113,724 | -72,476 | -24,622 |
| Depreciation Amortization | 3,929 | 2,024 | 7,146 | 5,105 | 3,028 |
| Accounts payable and accrued liabilities | 1,184 | 1,594 | -11,578 | -6,539 | -3,092 |
| Other Working Capital | -25,790 | -9,153 | -58,977 | -21,573 | -20,801 |
| Other Operating Activity | 18,633 | 10,432 | 59,779 | 25,628 | 34,887 |
| Operating Cash Flow | $-75,047 | $-35,236 | $-117,354 | $-69,855 | $-10,600 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -161 | -62 | -7,975 | -7,098 | -5,301 |
| Purchase Of Investment | N/A | N/A | -4,426 | -4,426 | -4,426 |
| Sale Of Investment | 1,401 | N/A | 22,983 | 22,983 | 22,983 |
| Investing Cash Flow | $1,240 | $-62 | $10,582 | $11,459 | $13,256 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | 103,378 | 103,378 | 103,378 |
| Debt Repayment | N/A | N/A | -52,860 | -52,860 | -52,860 |
| Common Stock Issued | 18,762 | 18,762 | 21,187 | 14,758 | 13,315 |
| Financing Cash Flow | $18,762 | $18,762 | $71,705 | $65,276 | $63,833 |
| Exchange Rate Effect | N/A | N/A | 2 | 2 | 1 |
| Beginning Cash Position | 136,150 | 136,150 | 171,215 | 171,215 | 171,215 |
| End Cash Position | 81,105 | 119,614 | 136,150 | 178,097 | 237,705 |
| Net Cash Flow | $-55,045 | $-16,536 | $-35,065 | $6,882 | $66,490 |
| Free Cash Flow | |||||
| Operating Cash Flow | -75,047 | -35,236 | -117,354 | -69,855 | -10,600 |
| Capital Expenditure | -161 | -62 | -7,975 | -7,098 | -5,301 |
| Free Cash Flow | -75,208 | -35,298 | -125,329 | -76,953 | -15,901 |